FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+36.88%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$221M
AUM Growth
+$221M
(+17%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-6.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
5
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$5.41M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$4.03M |
| 3 |
Insmed
INSM
|
$1.4M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$978K |
| 5 |
Natera
NTRA
|
$964K |
Sector Composition
| 1 | Healthcare | 36.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $79.5M | 35.87% |
1,672,714
| – | – |
|
|
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $60.9M | 27.51% |
2,726,568
-242,081
| -8% | -$5.41M |
|
|
3
Insmed
INSM
$30.7B
| $26.7M | 12.07% |
919,436
-48,200
| -5% | -$1.4M |
|
|
ALDR
4
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $21.7M | 9.78% |
1,586,220
| – | – |
|
|
EPZM
5
DELISTED
Epizyme, Inc
EPZM
| $18.4M | 8.33% |
1,488,444
-69,420
| -4% | -$860K |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.78M | 3.97% |
188,602
-21,000
| -10% | -$978K |
|
|
BDSI
7
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.8M | 1.72% |
717,133
-79,600
| -10% | -$422K |
|
8
Twist Bioscience
TWST
$1.58B
| $1.69M | 0.76% |
72,849
| – | – |
|
|
ADAP
9
Adaptimmune Therapeutics
ADAP
$15.3M
| – | – |
-700,000
| Closed | -$4.03M |
|
|
10
Natera
NTRA
$23.2B
| – | – |
-69,045
| Closed | -$964K |
|